Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Exact Sciences Corporation

Exact Sciences Corporation (EXAS) Stock Overview

Explore Exact Sciences Corporation’s financial performance, market position, analyst ratings, and future outlook.

EXAS●NASDAQ
HealthcareMedical - Diagnostics & Research
$104.91
$0.00(0.00%)
U.S. Market opens in 12h 46m

Exact Sciences Corporation (EXAS)

Meyka AI Score

Z

Key Financials

Market Cap20B
P/E Ratio-95.69
EPS (TTM)$-1.10
ROE-0.09%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$58.16

EXAS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Exact Sciences Corporation (NASDAQ: EXAS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Exact Sciences Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of EXAS on the NASDAQ shows an RSI of 0.00, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $58.16 for the NASDAQ listing.

Key metrics behind Exact Sciences Corporation's NASDAQ-traded stock include a P/E ratio of -95.69 and a market capitalization of 20B. Combined with our AI analysis, these give both institutional and retail investors a clear view of EXAS on the NASDAQ.

Price Performance (NASDAQ: EXAS)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
2.48%
6-Month Change
66.76%
Year-to-Date (YTD) Change
3.30%
1-Year Change
137.62%
3-Year Change
58.45%
5-Year Change
-19.28%
All-Time (Max) Change
599.40%

Contact Information

https://www.exactsciences.com
608 284 5700
5505 Endeavor Lane, Madison, WI, 53719

Company Facts

69,000 Employees
IPO DateFeb 1, 2001
CountryUS

Frequently Asked Questions